Evidence map›Paper›PMID 32917984›Full record

ArticleCellular & molecular immunology2021

Kidney GATA3

Ryota Sakai, Minako Ito, Kyoko Komai, Mana Iizuka-Koga, Kazuhiko Matsuo, Takashi Nakayama, Osamu Yoshie, Koichi Amano, Hiroshi Nishimasu, Osamu Nureki and 2 more

Abstract read
In one paragraph

Article in Cellular & molecular immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. The hidden players: LncRNA-Encoded micropeptides in cancer hallmarks.Cellular and molecular life sciences : CMLS · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Setd2 supports GATA3Nature communications · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ryota SakaiDepartment of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. r_sakai@saitama-med.ac.jp.
Minako ItoMedical Institute of Bioregulation Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Kyoko KomaiDepartment of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Mana Iizuka-KogaDepartment of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Kazuhiko MatsuoDivision of Chemotherapy, Kindai University Faculty of Pharmacy, Higashi-Osaka, 577-8502, Japan.
Takashi NakayamaDivision of Chemotherapy, Kindai University Faculty of Pharmacy, Higashi-Osaka, 577-8502, Japan.
Osamu YoshieThe Health and Kampo Institute, Sendai, Miyagi, 981-3205, Japan.
Koichi AmanoDepartment of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, 350-8550, Japan.
Hiroshi NishimasuDepartment of Biological Science, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Osamu NurekiDepartment of Biological Science, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Masato KuboCenter for Animal Disease Models, Research Institute for Biomedical Science, Tokyo University of Science, 2669 Yamazaki, Noda-shi, Chiba, 278-0022, Japan.
Akihiko YoshimuraDepartment of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. yoshimura@keio.jp.

Funding

Japan Agency for Medical Research and Development (AMED) 20gm1110009Japan Agency for Medical Research and Development (AMED) 20gm6210012MEXT | Japan Society for the Promotion of Science (JSPS) 17K15667MEXT | Japan Society for the Promotion of Science (JSPS) 19H04817MEXT | Japan Society for the Promotion of Science (JSPS) 19K16618MEXT | Japan Society for the Promotion of Science (JSPS) JP17H06175MEXT | Japan Society for the Promotion of Science (JSPS) JP18H05376
6 · The paper itself

Abstract

FoxP3

Indexed as

ConvalescenceAmphiregulinAnimalsAntibodiesDisease Models, AnimalGATA3 Transcription FactorGlomerulonephritisInflammationInterleukin-1 Receptor-Like 1 ProteinInterleukin-33KidneyLymphocyte SubsetsMiceMice, Inbred C57BLPhenotypePPAR gammaAmphiregulinAntibodiesAreg protein, mouseCcr4 protein, mouseGATA3 Transcription FactorIl1rl1 protein, mouseInterleukin-1 Receptor-Like 1 ProteinInterleukin-33PPAR gammaReceptors, CCR4Receptors, ChemokineautoantibodyGATA3IL-33kidneyTissue Tregs

Identifiers

PMID32917984
PMCPMC8093306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.